These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1182676)
21. Combination chemotherapy of advanced lung cancer: a randomized trial. Hansen HH; Selawry OS; Simon R; Carr DT; van Wyk CE; Tucker RD; Sealy R Cancer; 1976 Dec; 38(6):2201-7. PubMed ID: 187312 [TBL] [Abstract][Full Text] [Related]
22. Chemotherapy in bronchogenic carcinoma. Ojala A; Nikkanen VN; Palojoki A; Paloheimo S Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741 [TBL] [Abstract][Full Text] [Related]
23. Methotrexate in the chemotherapy of lung cancer. Smyth JF; Ford HT Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986 [TBL] [Abstract][Full Text] [Related]
24. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma]. Castberg T; Kruse-Blinkenberg HO Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973 [No Abstract] [Full Text] [Related]
25. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma. Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846 [No Abstract] [Full Text] [Related]
26. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma]. Nagorni-Obradović L Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789 [TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan. Bonadonna G; Tancini G; Bajetta E Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741 [No Abstract] [Full Text] [Related]
28. Cyclophosphamide in disseminated bronchial carcinoma. Cameron SJ; Grant IW; Crompton GK Scott Med J; 1974 Mar; 19(2):81-6. PubMed ID: 4365318 [No Abstract] [Full Text] [Related]
30. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens. Behera D; Malik SK Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339 [TBL] [Abstract][Full Text] [Related]
31. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients. Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109 [TBL] [Abstract][Full Text] [Related]
32. Subset of patients with verrucous carcinoma of the oral cavity who benefit from treatment with methotrexate. Karagozoglu KH; Buter J; Leemans CR; Rietveld DH; van den Vijfeijken S; van der Waal I Br J Oral Maxillofac Surg; 2012 Sep; 50(6):513-8. PubMed ID: 22000636 [TBL] [Abstract][Full Text] [Related]
33. Methyl-CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma. Richards F; Cooper MR; Muss HB; White DR; Spurr CL Cancer; 1976 Sep; 38(3):1077-82. PubMed ID: 953956 [TBL] [Abstract][Full Text] [Related]
34. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma. Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172 [TBL] [Abstract][Full Text] [Related]
35. Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients. Cohen MH; Creaven PJ; Fossieck BE; Johnston AV; Williams CL Cancer; 1976 Oct; 38(4):1556-9. PubMed ID: 186170 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group. Karrer K; Pridun N; Zwintz E Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324 [No Abstract] [Full Text] [Related]
37. The use of chemotherapy in lung cancer (controlled trials). Shnider BI Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653 [No Abstract] [Full Text] [Related]
38. Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer. Band PR; Ross CA; Holland JF Cancer Chemother Rep; 1973 Feb; 57(1):79-82. PubMed ID: 4704106 [No Abstract] [Full Text] [Related]